The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Research Report 2024
Synopsis
Nuclear Medicine Cyclotron Systems are specialized devices used in the production of radionuclides for medical imaging applications. These systems play a crucial role in the field of nuclear medicine, where radioactive isotopes are utilized to diagnose and treat various medical conditions. A cyclotron is a type of particle accelerator that accelerates charged particles in a circular path.
The global Nuclear Medicine Cyclotron Systems for Radionuclides market was valued at US$ 202.3 million in 2023 and is anticipated to reach US$ 274.2 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for Nuclear Medicine Cyclotron Systems for Radionuclides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems for Radionuclides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nuclear Medicine Cyclotron Systems for Radionuclides include GE Healthcare, IBA, Best Cyclotron Systems, Advanced Cyclotron Systems (ACSI), Sumitomo Heavy Industries and Longevous Beamtech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Cyclotron Systems for Radionuclides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Cyclotron Systems for Radionuclides.
Report Scope
The Nuclear Medicine Cyclotron Systems for Radionuclides market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine Cyclotron Systems for Radionuclides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Cyclotron Systems for Radionuclides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
IBA
Best Cyclotron Systems
Advanced Cyclotron Systems (ACSI)
Sumitomo Heavy Industries
Longevous Beamtech
Segment by Type
Cyclotron Less than 12 MeV
Cyclotron 13-18 MeV
Cyclotron 19-24 MeV
Cyclotron More than 24 MeV
Segment by Application
Diagnosis Radionuclides
Treatment Radionuclides
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine Cyclotron Systems for Radionuclides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine Cyclotron Systems for Radionuclides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nuclear Medicine Cyclotron Systems are specialized devices used in the production of radionuclides for medical imaging applications. These systems play a crucial role in the field of nuclear medicine, where radioactive isotopes are utilized to diagnose and treat various medical conditions. A cyclotron is a type of particle accelerator that accelerates charged particles in a circular path.
The global Nuclear Medicine Cyclotron Systems for Radionuclides market was valued at US$ 202.3 million in 2023 and is anticipated to reach US$ 274.2 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for Nuclear Medicine Cyclotron Systems for Radionuclides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems for Radionuclides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nuclear Medicine Cyclotron Systems for Radionuclides include GE Healthcare, IBA, Best Cyclotron Systems, Advanced Cyclotron Systems (ACSI), Sumitomo Heavy Industries and Longevous Beamtech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Cyclotron Systems for Radionuclides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Cyclotron Systems for Radionuclides.
Report Scope
The Nuclear Medicine Cyclotron Systems for Radionuclides market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine Cyclotron Systems for Radionuclides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Cyclotron Systems for Radionuclides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
IBA
Best Cyclotron Systems
Advanced Cyclotron Systems (ACSI)
Sumitomo Heavy Industries
Longevous Beamtech
Segment by Type
Cyclotron Less than 12 MeV
Cyclotron 13-18 MeV
Cyclotron 19-24 MeV
Cyclotron More than 24 MeV
Segment by Application
Diagnosis Radionuclides
Treatment Radionuclides
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine Cyclotron Systems for Radionuclides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine Cyclotron Systems for Radionuclides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nuclear Medicine Cyclotron Systems for Radionuclides Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Cyclotron Systems for Radionuclides
1.2 Nuclear Medicine Cyclotron Systems for Radionuclides Segment by Type
1.2.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Value Comparison by Type (2024-2030)
1.2.2 Cyclotron Less than 12 MeV
1.2.3 Cyclotron 13-18 MeV
1.2.4 Cyclotron 19-24 MeV
1.2.5 Cyclotron More than 24 MeV
1.3 Nuclear Medicine Cyclotron Systems for Radionuclides Segment by Application
1.3.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Value by Application: (2024-2030)
1.3.2 Diagnosis Radionuclides
1.3.3 Treatment Radionuclides
1.4 Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue 2019-2030
1.4.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales 2019-2030
1.4.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nuclear Medicine Cyclotron Systems for Radionuclides Market Competition by Manufacturers
2.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Average Price by Manufacturers (2019-2024)
2.4 Global Nuclear Medicine Cyclotron Systems for Radionuclides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems for Radionuclides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems for Radionuclides, Product Type & Application
2.7 Nuclear Medicine Cyclotron Systems for Radionuclides Market Competitive Situation and Trends
2.7.1 Nuclear Medicine Cyclotron Systems for Radionuclides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine Cyclotron Systems for Radionuclides Players Market Share by Revenue
2.7.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Medicine Cyclotron Systems for Radionuclides Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Region: 2019-2030
3.2.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Region: 2019-2024
3.2.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Region: 2025-2030
3.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Region: 2019-2030
3.3.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Region: 2019-2024
3.3.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Region: 2025-2030
3.4 North America Nuclear Medicine Cyclotron Systems for Radionuclides Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine Cyclotron Systems for Radionuclides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Country (2019-2030)
3.4.3 North America Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nuclear Medicine Cyclotron Systems for Radionuclides Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine Cyclotron Systems for Radionuclides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Country (2019-2030)
3.5.3 Europe Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Nuclear Medicine Cyclotron Systems for Radionuclides Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Medicine Cyclotron Systems for Radionuclides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Country (2019-2030)
3.6.3 Asia Pacific Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Nuclear Medicine Cyclotron Systems for Radionuclides Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine Cyclotron Systems for Radionuclides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Country (2019-2030)
3.7.3 Latin America Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nuclear Medicine Cyclotron Systems for Radionuclides Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine Cyclotron Systems for Radionuclides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Type (2019-2030)
4.1.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Type (2019-2024)
4.1.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Type (2025-2030)
4.1.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales Market Share by Type (2019-2030)
4.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Type (2019-2030)
4.2.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Type (2019-2024)
4.2.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Type (2025-2030)
4.2.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue Market Share by Type (2019-2030)
4.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Application (2019-2030)
5.1.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Application (2019-2024)
5.1.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales by Application (2025-2030)
5.1.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Sales Market Share by Application (2019-2030)
5.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Application (2019-2030)
5.2.1 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Application (2019-2024)
5.2.2 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue by Application (2025-2030)
5.2.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Revenue Market Share by Application (2019-2030)
5.3 Global Nuclear Medicine Cyclotron Systems for Radionuclides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Nuclear Medicine Cyclotron Systems for Radionuclides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Nuclear Medicine Cyclotron Systems for Radionuclides Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 IBA
6.2.1 IBA Corporation Information
6.2.2 IBA Description and Business Overview
6.2.3 IBA Nuclear Medicine Cyclotron Systems for Radionuclides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 IBA Nuclear Medicine Cyclotron Systems for Radionuclides Product Portfolio
6.2.5 IBA Recent Developments/Updates
6.3 Best Cyclotron Systems
6.3.1 Best Cyclotron Systems Corporation Information
6.3.2 Best Cyclotron Systems Description and Business Overview
6.3.3 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems for Radionuclides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems for Radionuclides Product Portfolio
6.3.5 Best Cyclotron Systems Recent Developments/Updates
6.4 Advanced Cyclotron Systems (ACSI)
6.4.1 Advanced Cyclotron Systems (ACSI) Corporation Information
6.4.2 Advanced Cyclotron Systems (ACSI) Description and Business Overview
6.4.3 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems for Radionuclides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems for Radionuclides Product Portfolio
6.4.5 Advanced Cyclotron Systems (ACSI) Recent Developments/Updates
6.5 Sumitomo Heavy Industries
6.5.1 Sumitomo Heavy Industries Corporation Information
6.5.2 Sumitomo Heavy Industries Description and Business Overview
6.5.3 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems for Radionuclides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems for Radionuclides Product Portfolio
6.5.5 Sumitomo Heavy Industries Recent Developments/Updates
6.6 Longevous Beamtech
6.6.1 Longevous Beamtech Corporation Information
6.6.2 Longevous Beamtech Description and Business Overview
6.6.3 Longevous Beamtech Nuclear Medicine Cyclotron Systems for Radionuclides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Longevous Beamtech Nuclear Medicine Cyclotron Systems for Radionuclides Product Portfolio
6.6.5 Longevous Beamtech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine Cyclotron Systems for Radionuclides Industry Chain Analysis
7.2 Nuclear Medicine Cyclotron Systems for Radionuclides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine Cyclotron Systems for Radionuclides Production Mode & Process
7.4 Nuclear Medicine Cyclotron Systems for Radionuclides Sales and Marketing
7.4.1 Nuclear Medicine Cyclotron Systems for Radionuclides Sales Channels
7.4.2 Nuclear Medicine Cyclotron Systems for Radionuclides Distributors
7.5 Nuclear Medicine Cyclotron Systems for Radionuclides Customers
8 Nuclear Medicine Cyclotron Systems for Radionuclides Market Dynamics
8.1 Nuclear Medicine Cyclotron Systems for Radionuclides Industry Trends
8.2 Nuclear Medicine Cyclotron Systems for Radionuclides Market Drivers
8.3 Nuclear Medicine Cyclotron Systems for Radionuclides Market Challenges
8.4 Nuclear Medicine Cyclotron Systems for Radionuclides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
